Aldeyra Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Aldeyra Therapeutics Stock Forecast and Price Target
If the average price target of $10.00 set by distinguished experts for Aldeyra Therapeutics over the past few weeks is reached this year, there would be a potential upside of approximately 137.53% from the last closing price in May, 2024. This potential increase is based on a high estimate of $11.00 and a low estimate of $7.00. If you are interested in ALDX stock, it is important to also consider its competitors.
137.53% Upside
Aldeyra Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
Aldeyra Therapeutics's Price has grown in the last four years, jumping from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach $4.52 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
.jpg)
Aldeyra Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
Aldeyra Therapeutics's EBITDA has increased by 61.14% In the last two years, going from $-34.61M to $-55.77M. In the next year, analysts expect EBITDA to reach $-87.36M – an increase of 56.64%. For the next seven years, the forecast is for EBITDA to grow by 30.09%.
Aldeyra Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Aldeyra Therapeutics's EBIT has grown, increasing from $-34.67M to $-62.68M – a growth of 80.79%. According to 6 major analysts, Aldeyra Therapeutics's EBIT will fall by 33.09% in the next year, reaching $-41.94M. Professionals believe that By 2030, Aldeyra Therapeutics's EBIT will fall to $133.51M– a 313.00% decrease from its current value.
Aldeyra Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Aldeyra Therapeutics's EPS has grown in the last four years, jumping from $-1.11 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach $-1.15 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)